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Maintenance of an Acidic Stratum Corneum Prevents
Emergence of Murine Atopic Dermatitis
Yutaka Hatano1,2, Mao-Qiang Man1,2, Yoshikazu Uchida1,2, Debra Crumrine1,2, Tiffany C. Scharschmidt1,2,
Esther G. Kim1,2, Theodora M. Mauro1,2, Kenneth R. Feingold3,4, Peter M. Elias1,2 and Walter M. Holleran1,2,5
Neutralization of stratum corneum (SC) adversely impacts key epidermal functions, including permeability
barrier homeostasis and SC integrity. Conversely, acidification of SC improves these functions in
developmentally impaired (neonatal or aged) skin, and enhances function in normal skin. Hence, we
hypothesized that acidification could alter the course of inflammatory dermatoses, which invariably exhibit an
increased SC pH. Maintenance of a low pH by topical applications of the polyhydroxyl acid, lactobionic acid,
during the repeated-challenge phase inhibited the development of oxazolone-induced atopic dermatitis (AD).
Neither gross/histological dermatitis nor altered barrier function developed, and emergence of epidermal
hyperplasia was prevented; however, cytokine generation decreased. Acidification also largely normalized the
development of hapten-induced changes in eosinophil/mast cell densities, density of chemoattractant receptor-
homologous molecule expressed on TH2-positive lymphocytes, and serum IgE levels. The pH-induced
improvement in barrier function most likely accounts for the anti-inflammatory activity, which could be further
attributed to normalization of both lamellar body secretion and lamellar bilayer formation. Acidification of SC
alone substantially prevents development of barrier abnormalities and downstream immune abnormalities
during the elicitation phase of murine AD. These results provide direct evidence for the ‘‘outside–inside’’
pathogenesis of AD and further suggest that maintenance of an acidic SC pH could prevent the emergence of
AD in humans.
Journal of Investigative Dermatology (2009) 129, 1824–1835; doi:10.1038/jid.2008.444; published online 29 January 2009
INTRODUCTION
The normally acidic pH of stratum corneum (SC) regulates
several key protective functions of the skin, including
permeability barrier homeostasis (Mauro et al., 1998; Fluhr
et al., 2001; Hachem et al., 2003), SC integrity and cohesion
(the converse of desquamation) (Fluhr et al., 2001; Hachem
et al., 2003), antimicrobial defense (Schade, 1928; Korting
et al., 1990; Elias, 2007), as well as primary cytokine
activation (Hachem et al., 2002). Accordingly, both in
developmentally impaired (neonatal (Behne et al., 2003;
Fluhr et al., 2004), aged (Choi et al., 2007a)) and inflamed
skin [reviewed by Fluhr and Elias, 2002), the pH of SC
increases toward neutrality. The increased pH of SC alone
inactivates lipid-processing enzymes that generate ceramides
in SC, although simultaneously activating a family of serine
proteases (SPs) (that is, kallikreins), which compromise SC
structure and function by divergent downstream mechanisms
(Hachem et al., 2003, 2005b).
As pH regulates so many key cutaneous functions, we
recently explored the efficacy of therapeutic approaches that
normalized (lowered) pH in developmentally impaired
settings. In separate reports, we first showed that hyperaci-
difying the SC with the polyhydroxyl acids (PHAs) enhances
the structure and function of normal mouse skin (Hachem
et al., 2009). Moreover, topical PHAs normalized pH and
barrier function in parallel both in neonatal (Fluhr et al.,
2004) and in moderately aged (Choi et al., 2007b) human
and rodent skin. In both age groups, lowering of pH in turn
corrected the epidermal structural and functional abnormal-
ities that distinguish these divergent age groups from young
(normal) skin. In this study, we assessed hyperacidification as
a preventive/therapeutic strategy in a recently described
model of hapten-induced atopic dermatitis (AD) in hairless
mice (Man et al., 2008). In this model, an initial sensitizing
dose with the hapten, oxazolone (Ox), followed 1 week later
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by a single challenge dose, elicits acute allergic contact
dermatitis (Sheu et al., 2002; Fowler et al., 2003). If sensitized
mice then are challenged repeatedly (10 doses over 3 weeks),
an AD-like dermatitis evolves (Man et al., 2008). This
oxazalone-induced atopic-like dermatitis (Ox-AD) model
recapitulates virtually every clinical, structural, lipid biochem-
ical, and immunological feature of human AD, including: (i) a
chronic, pruritic, inflammatory dermatosis, (ii) elevated transe-
pidermal water loss (TEWL) levels; (iii) ultrastructural and lipid
biochemical abnormalities typical of AD; (iv) tissue eosinophi-
lia, elevated serum IgE levels, and a Th2-dominant immuno-
phenotype; and (v) decreased expression of two key
antimicrobial peptides (AMPs), that is, cathelicidin-related
antimicrobial peptide (CRAMP), the mouse homolog of the
human cathelicidin carboxy-terminal fragment, LL-37, and
mBD3, the murine homolog of human b-defensin 2 (Man et al.,
2008). Pertinent to this study, the mice also develop an
elevated surface pH, as in human AD (cited in the review by
Man et al., 2008). Therefore, we asked here whether SC
acidification could either prevent emergence of or reverse Ox-
induced acute allergic contact dermatitis or AD. Reduction of
the pH of SC with the PHA, lactobionic acid (LBA), did not
modify the clinical, structural, functional, or biochemical
abnormalities either in hapten-induced acute allergic contact
dermatitis or in established Ox-AD, whereas maintenance of an
acidic SC pH during the 3-week challenge phase largely
prevented emergence of key components of Ox-AD. We show
here further that the responsible mechanisms are pH-depen-
dent improvements in barrier function, rather than anti-
inflammatory effects of the LBA, providing further support for
the ‘‘outside–inside’’ concept of AD pathogenesis (Elias et al.,
1999, 2008; Taieb, 1999).
RESULTS
SC acidification prevents emergence of the pH abnormality, but
does not prevent the development of acute allergic contract
dermatitis
After the initial Ox challenge (Figure 1a), surface pH
increases by 6 hours, well before the appearance of acute
allergic contact dermatitis (Figure 1b), and surface pH
remains increased during subsequent Ox challenges that
eventually elicit an AD-like dermatosis (Man et al., 2008).
Therefore, we first assessed whether the reduction of pH,
achieved with applications of the PHA, LBA, immediately
before, coincident with, or immediately after the first
challenge dose, would prevent or delay the development of
the pH abnormality in singly or repeatedly Ox-challenged
mice (Figure 1a). In control animals, challenged one time
with Ox alone, the mean surface pH increased from a mean
of 5.7 to a mean of 6.3 by 8 hours, remaining increased for
24 hours before slowly normalizing over 48 hours (Figure 1b).
By applying LBA immediately after the initial Ox challenge,
and then twice daily thereafter, skin surface pH could be
maintained at normal or subnormal levels (p5) over the
48 hours post-challenge period (Figure 1c).
Dual-photon, fluorescence lifetime imaging analysis
allows localization of pH changes both at different levels of
SC and in cellular (cytosolic) versus membrane (‘‘extracel-
lular’’) domains (Behne et al., 2002). With fluorescence
lifetime imaging, the LBA-induced reduction in pH could be
seen to extend to all SC layers, with a further selective
reduction of pH within extracellular (membrane) domains of
the SC where SP and lipid-processing enzymes function, a
difference that became more prominent deep in the SC
(Figure 1d, representative experiment). Taken together, these
results show that pH levels can be maintained at or below
normal levels by the topical PHA, even in the face of single or
repeated hapten challenges (cf., Figure 1c).
We next assessed whether maintenance of an acidic pH
with topical LBA prevents development of hapten-induced
acute allergic contact dermatitis (Figure 1a). LBA applications
alone do not change ear thickness. Although both pre-
applications and co-applications of LBA with Ox maintained
an acidic SC pH (Figure 1) and normalized permeability
barrier function (Figure S2a), Ox-challenged mice never-
theless developed levels of inflammation that were compar-
able with mice treated with either Ox plus neutralized LBA
(nLBA) or Ox plus vehicle alone (Figure S1). These results
were confirmed quantitatively both as an increase in ear
thickness and as an increase in T-cell density (CD3-positive
cells) occurred in singly challenged mice, regardless of the
initial pH of the SC (Figures S1b and S2b). As neither topical
pre-acidification nor co-acidification (Figures S1 and S2b)
prevents development of hapten-induced acute allergic
contact dermatitis, acidification with LBA most likely alters
neither the antigenicity of the hapten nor hapten penetration.
Taken together, these results show that LBA applications,
despite maintaining an acidic SC pH and normal barrier
function, do not prevent the emergence of Ox-induced acute
allergic contact dermatitis.
SC acidification prevents the development of Ox-AD
We next assessed whether normalization of SC pH would
reverse preestablished Ox-AD. Reductions in SC pH alone
altered neither gross nor histological evidence of inflamma-
tion or epidermal hyperplasia, nor did they normalize
epidermal structure and function (data not shown). Therefore,
we next asked whether maintenance of an acidic pH during
the repeated-challenge phase would prevent emergence of
Ox-AD (AD model; Figure 1a). In contrast to acute allergic
contact dermatitis, maintenance of an acidic pH largely
prevented emergence of Ox-AD (Figure 2a). Specifically,
LBA-cotreated mice showed reduced erythema, scale, and
almost no excoriations, indicative of pruritus, in comparison
with Ox plus vehicle- or Ox plus nLBA-treated mice. As
noted previously (Man et al., 2008), mice repeatedly
challenged with either Ox plus vehicle alone or Ox plus
nLBA develop abnormal permeability barrier function (TEWL
levels increased six- to eightfold), reduced SC hydration, and
notably a 1–1.5U increase in surface pH (Figure 2b–d). In
contrast, these functional abnormalities did not emerge when
the SC remained acidic with LBA applications during the
hapten-challenge phase (Figure 2b–d; results for each
parameter are statistically significant versus either Ox plus
vehicle or Ox plus nLBA; Po0.01). Thus, maintenance of an
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acidic SC pH largely prevents the emergence of the
macroscopic and functional abnormalities in Ox-AD.
Histological studies further showed the ability of acid-
ification to largely prevent the development of both dermal
inflammation and epidermal hyperplasia in hematoxylin-and-
eosin sections (Figure 3a). Both epidermal thickness and
epidermal proliferation, assessed as the density of proliferat-
ing cell nuclear antigen (PCNA)-positive cells, also were
largely normalized by hyperacidification (Figure 3b–d). Taken
together, these studies show that hyperacidification prevents
the emergence of Ox-AD, including the maintenance of
normal barrier function, as well as a significant reduction in
both epidermal hyperplasia and histological evidence of
inflammation.
SC acidification attenuates the development of Th2-dominant
inflammation in Ox-AD mice
Although single Ox challenges provoke a Th1-dominant
immunophenotype, with relatively low serum IgE levels,
repeated Ox challenges that lead to Ox-AD are associated
with both a Th2 immunophenotype and very high serum IgE
levels (Man et al., 2008). We next assessed whether
maintenance of an acidic pH with topical LBA prevents the
emergence of the Th2 immunophenotype. Repeated Ox
challenges, with or without co-applications of vehicle or
nLBA (cf., Figure 1a), provoked a dense inflammatory
infiltrate (Figure 3a), enriched in CTRH2-positive T cells
(Figure 4a), an observation that was confirmed by quantita-
tive studies (Figure 4b). In contrast, development of the
chemoattractant receptor-homologous molecule expressed
on TH2 (CRTH2)-positive cellular infiltrate was inhibited
significantly when the SC remained acidified during Ox
challenges (cf. Figure 4a versus b). Moreover, serum IgE
levels decreased, a decrease that achieved statistical sig-
nificance (Figure 4e). Yet, acidification did not reduce serum
levels of thymus and activation-regulated cytokine (TARC),
an epidermis-derived chemokine that signals Th2 cells, in
acidified Ox-AD mice (Figure S3), reflecting the partial effect
of SC acidification on inflammation induced by repetitive Ox
challenges. Finally, both tissue mast cells (including both
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Figure 1. Topical PHA prevents the hapten-induced increase in stratum corneum pH. Individual challenges with 0.1% oxazolone (Ox) were performed in hairless
mice (h/kr) (n¼8 in each group), sensitized 7 days previously with 1% Ox as described in Materials and Methods. Parallel groups of normal mice were treated
with the ethanol vehicle (EtOH) alone. (a–c) LBA, a neutralized solution of LBA (nLBA), or vehicle were applied to Ox-sensitized mice at the time points indicated
by the bold arrows (four times during the 48hours between Ox challenges). (a) Experimental time line; (b) changes in surface pH over time after a single Ox
challenge dose; (c) changes in surface pH in Ox-challenged mice, cotreated with LBA, nLBA, vehicle, or nonsensitized mice treated with vehicle alone (treatment
time is shown by bold vertical arrows). (d) Changes in extracellular and intracellular pH within different SC microdomains after single Ox challenge plus co-applied
LBA or vehicle, assessed by fluorescence life-time imaging. Ox challenge results in a significantly more neutral intracellular than extracellular pH in the mid- and
lower SC, which was corrected by co-applications of LBA with Ox. Note: LBA acidifies both intracellular and extracellular domains of the SC.
1826 Journal of Investigative Dermatology (2009), Volume 129
Y Hatano et al.
Maintenance of an Acidic SC Prevents Murine AD
total and degranulated) and eosinophil densities were largely
normalized in LBA-treated, Ox-AD mice (Figure 5a–e). Taken
together, these results show that the maintenance of an acidic
SC pH attenuates the development of a Th2-dominant
infiltrate in Ox-AD mice.
SC acidification normalizes antimicrobial peptide expression in
Ox-AD mice
We next assessed whether co-acidification would normalize
AMP expression in Ox-AD mice. Previous studies showed
that levels of both CRAMP (murine homolog of LL-37) and
mBD3 (murine homolog of human b-defensin 2) decrease in
Ox-AD mice (Man et al., 2008). Co-acidification normalized
or even supernormalized both CRAMP and mBD3 immuno-
staining in the outer epidermis in comparison with either Ox
plus nLBA- or Ox plus Veh-treated skin (Figure 6; Ox plus
nLBA not shown). These results suggest that the maintenance
of an acidic pH prevents the hapten-induced decrease in
AMP expression in Ox-AD skin.
Enzymatic and structural basis for the attenuation of Ox-AD by
SC acidification
A sustained increase in the pH of the SC has deleterious
consequences for normal mice, including provocation of
permeability barrier dysfunction (Hachem et al., 2003,
2005b). These abnormalities could be further attributed to a
parallel increase in SP activity, which, if sustained,
degrades lipid-processing enzymes and blocks lamellar body
(LB) secretion (Hachem et al., 2005b, 2006a). Likewise,
a pH-induced increase in SP activity correlated with
abnormal barrier function in Ox-AD mice (Man et al.,
2008). Owing to the potential, central role of pH-induced
increases in SP activity, we next assessed enzyme
activity zymographically in frozen sections of Ox-AD mouse
skin, with or without concurrent LBA cotreatment.
Whereas control (nonsensitized, ethanol vehicle-treated)
mice showed low levels of SP activity (Figure 7a), Ox-AD
mice cotreated with either vehicle alone or nLBA
(Ox plus Veh not shown) showed an intense band of SP
activity at all levels of the SC, consistent with the Ox-induced
elevation in pH (Figure 7a; cf. Figure 1b). In contrast, Ox-AD
mice cotreated with LBA showed normal or even subnormal
levels of SP activity. We next assessed whether SC acidifica-
tion normalizes barrier function by ‘‘rescuing’’ the lipid-
processing enzyme, b-glucocerebrosidase (b-GlcCer’ase)
(Takagi et al., 1999). Again, by in situ zymography,
cotreatment with LBA largely normalized the activity of this
critical lipid-processing enzyme (Figure 7b).
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Figure 2. Maintenance of normal pH prevents emergence of hapten-induced, murine atopic dermatitis. (a) Macroscopic (clinical) appearance of repeated
Ox-challenged mice, cotreated with topical LBA or controls, as above. (b–d) Transepidermal water loss (TEWL), pH and hydration (electrical capacitance) were
measured after the tenth Ox challenge, as described in Materials and Methods. Normal control group indicates mice treated with the ethanol vehicle instead of
Ox. Vehicle indicates control group in which water/ethanol (7:3) was applied twice daily instead of LBA or nLBA during repeated Ox challenges (cf., Figure 1a).
LBA/nLBA: LBA/nLBA treatment group in which LBA/nLBA in water/ethanol (7:3) was applied twice daily, whereas Ox challenges were continued every other
day. Each experiment was repeated twice and representative data are shown. For TEWL and SC hydration, n¼ 24; for pH, n¼ 16.
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Human AD is characterized by decreased secretion of
epidermal LBs (Fartasch, 1997), leading to decreased
generation of extracellular lamellar bilayers (Chamlin et al.,
2002). Hence, we next assessed the LB secretory system in
Ox-AD mice treated with vehicle, nLBA, or LBA. Neither the
density nor the internal contents of LB appeared altered in
repeatedly Ox-challenged mouse epidermis (Figure 8a). Yet,
there was a paucity of secreted LB contents at the stratum
granulosum (SG)–SC interface, with accumulation of unse-
creted LB in the apical cytosol of outermost SG cells. Thus,
the apparent, partial failure of exocytosis is reflected by the
entombment of substantial numbers of LB within nascent
corneocytes (Figure 8a). In contrast, LB secretion appeared to
be unimpaired in LBA-treated Ox-AD mice (Figure 8c).
To verify further that LB secretion is impaired in Ox-AD
mice, we next assessed changes in the localization of the
activity of an LB content marker, acidic lipase, by
ultrastructural cytochemistry. In Ox-challenged mice,
cotreated with either nLBA or vehicle, the partial blockade
of LB secretion was confirmed by the visible entombment
of acid lipase activity within nascent corneocytes (Figure 8b).
Notably, in Ox-AD mice cotreated with LBA, all of the LB
content marker appeared between corneocytes (Figure 8d),
indicating unimpaired secretion, as in normal mice.
Ox-AD mice cotreated with LBA also exhibited both
fewer LB in the SG cell cytosol and evidence of
abundant (complete) secretion at the SG–SC interface
(cf. Figure 8a versus c). These results show that SC
acidification normalizes LB secretion, even in the face of
ongoing hapten challenges.
Finally, Ox-AD mice treated with either vehicle or nLBA
show a delay in the extracellular processing of secreted LB
contents into mature lamellar bilayers (Figures 9a, b, 10a and b).
Whereas Ox-AD mice showed a paucity of extracellular
bilayers in the SC, Ox-AD mice cotreated with LBA show a
relative abundance of mature extracellular lamellar bilayers
at comparable levels of the SC (Figure 10c). Taken together,
these results show that the maintenance of an acidic pH
prevents emergence of the enzymatic and structural abnorm-
alities that underlie the barrier abnormality in Ox-AD mice.
Maintenance of an acidic pH inhibits cytokine generation in
Ox-AD mice
We next assessed mechanisms whereby SC acidification
could prevent the development of inflammation in Ox-AD
mice. Barrier abnormalities result in a pH-induced increase in
SP activity (Hachem et al., 2003, 2005b), which, in turn, has
been shown to release IL-1b from the SC (Nylander-Lundqvist
and Egelrud, 1997). Immunostaining for both IL-1a and tumor
necrosis factor-a (TNFa) increased in Ox-AD mice treated
with either vehicle or nLBA (Figure 11; TNF not shown). In
contrast, maintenance of an acidic pH largely prevented
the expected increase in IL-1a and TNFa immunostaining
(Figure 11). Notably, the extent of the decrease was greater
than in clobetasol-treated Ox-AD, which also partially
attenuated cytokine immunostaining. These results show that
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Figure 3. Maintenance of a normal pH largely prevents emergence of epidermal hyperplasia. Skin samples were collected 48 hours after the tenth challenge
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maintenance of an acidic pH prevents generation of
epidermal primary cytokines in Ox-AD mice.
DISCUSSION
The pH of the SC influences at least four key epidermal
functions (permeability barrier homeostasis, integrity/cohe-
sion (desquamation), initiation of inflammation, and anti-
microbial defense) (Elias, 2005). Hence, the maintenance of
low acidity provides a mechanism that coordinately inte-
grates these key functions (Elias, 2005). The importance of pH
in vivo was first shown in experiments where permeability
barrier function is acutely abrogated, producing a parallel
elevation in pH (Mauro et al., 1998). Under these conditions,
it was pH itself, rather than barrier requirements, that
upregulated endogenous acidification mechanisms, that is,
sodium/hydrogen exchanger 1 (NHE1) antiporter expression—
barrier restoration alone did not influence the rate of
reacidification (Hachem et al., 2005a). As inflammatory
dermatoses often show parallel alterations in all four of the
above key functions, we asked here first whether main-
tenance of a normal or hyperacidic pH could reverse or
prevent either hapten-induced acute allergic contact derma-
titis or AD. Although exogenous SC acidification reversed
neither hapten-induced acute allergic contact dermatitis nor
preexistent Ox-AD, exogenous co-acidification alone re-
stricted development of hapten-induced AD. Indeed, acid-
ification of SC not only normalized epidermal structure and
function in the face of ongoing hapten challenges, but also
significantly attenuated most components of the inflamma-
tory response, including Th2 markers, epidermal hyperplasia,
tissue eosinophil and mast cell densities, and Th2 cell counts
within the residual infiltrate. Even serum IgE levels decreased
significantly with topical co-acidification. As neither pre- nor
co-acidification prevented the development of inflammation
during the AACD elicitation phase, despite normalizing
epidermal function, it seems safe to assume that our results
reflect neither a physical–chemical effect of acidification nor
interference with hapten absorption. Instead, our results
appear to show that it is pH-induced maintenance of normal
epidermal structure and function that most likely accounts for
the efficacy of this strategy in Ox-AD.
Normalization of barrier function most likely decreases
inflammation by two unrelated mechanisms. First, it most
likely restricts antigen access during repeated-challenge
phase, but this supposition must still be verified. These
studies suggest that an additional anti-inflammatory mechan-
ism is operative, that is, reduced evidence for cytokine
activation. Previous studies have shown that barrier disrup-
tion stimulates epidermal cytokine generation (Wood et al.,
1992; Nickoloff and Naidu, 1994); and conversely, normal-
ization of barrier function by occlusion decreases epidermal
primary cytokine generation in models of chronic inflamma-
tion (Wood et al., 1994a, b). The acidification-induced
reduction in cytokine generation most likely reflects the
observed reduction in SP activity (Nylander-Lundqvist and
Egelrud, 1997). In summary, it is most likely that both
mechanisms are operative (that is, decreased hapten ingress
and decreased cytokine activation), together accounting for
the ability of SC acidification to largely protect against the
development of inflammation in this mouse model of AD.
Our study provided additional mechanistic insights about
how maintenance of an acidic pH most likely prevents
emergence of the barrier abnormality in hapten-induced AD.
A characteristic structural feature of human AD is a reduction
in extracellular lamellar bilayers (Chamlin et al., 2002), as
also shown here for Ox-AD, most likely rendering the SC
more porous to transcutaneous water loss (and simulta-
neously more susceptible to pro-inflammatory ingress of
haptens). We confirmed here that the basis for this
abnormality in the Ox-AD model could be a pH-induced
increase in SP activity in the outer epidermis (Man et al.,
2008), with several potentially adverse consequences. The
increased pH of Ox-AD epidermis downregulates the
activities of the key ceramide-generating enzyme, b-gluco-
cerebrosidase, which shows an acidic pH optimum (reviewed
by Holleran et al., 2006). A sustained increase in SP
activity not only inactivates lipid-processing enzymes, but
also degrades the lipid-processing enzymes that generate
the lamellar bilayers that provide for barrier function
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Figure 4. Maintenance of a normal pH partially prevents emergence of TH2-
type inflammation. (a) Skin samples were collected 48 hours after the tenth
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(Hachem et al., 2005b). However, whether lipid-processing
enzyme protein content decreases in AD or in Ox-AD mice is
not known. SP-mediated inhibition of LB secretion also
occurs in Ox-AD, which most likely results from increased SP
signaling of the PAR2 receptor (Hachem et al., 2006a). It
should be noted that such a failure in both lipid secretion and
ceramide generation correlates with the reported reduction in
total SC lipids and further decrease in ceramide content that
occurs in human AD (Melnik et al., 1988; Imokawa et al.,
1991; Di Nardo et al., 1998). Finally, and in parallel,
abnormal/heightened SP-PAR2 binding could accelerate
terminal differentiation (physiological apoptosis or pro-
grammed cell death), a process that traps unsecreted LB
within the cytosol of nascent corneocytes (Demerjian et al.,
2008). Taken together, these mechanisms most likely account
for the observed abnormalities in lamellar bilayer structure,
and in an overall reduction in the quantities of extracellular
lamellae in Ox-AD, as well as the abnormal desquamation
(poor integrity) of the SC in AD (Cork et al., 2006).
Conversely, we show here that the maintenance of a reduced
pH improves permeability barrier function by preventing
emergence of many of the above-described pathogenic
mechanisms. Reduction in pH would not only allow optimal
lipid-processing enzyme activity, but also block SP-mediated
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Figure 6. Acidification normalizes or supernormalizes antimicrobial peptide expression in Ox-AD mice. Frozen sections (6mm) of Ox-AD skin cotreated with
vehicle (Veh) or LBA, incubated with primary antibodies against either mBD3 (top three panels) or CRAMP (bottom three panels), with propidium iodide as the
nuclear counterstain. Note decrease in Ox- plus Veh-treated skin, and increased (supernormal) immunostaining in LBA cotreated samples. Bar¼20 mm.
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degradation of these enzymes (previously shown to be a pH-
dependent process) (Hachem et al., 2005b, 2006b). In
support of these proposed mechanisms, we showed here b-
glucocerebrosidase activity increases in acidified, hapten-
challenged skin, as well as ultrastructural evidence of
accelerated lamellar membrane ‘‘maturation’’ in such acid-
ified sites, consistent with normalization of this enzyme
activity in the SC. Thus, the maintenance of an acidic pH
could normalize barrier function in murine AD by several
distinct, yet interdependent, mechanisms.
This work has implications for the primary or ancillary
prevention of AD, as topical PHAs, such as LBA, are ‘‘GRAS’’
ingredients, that is, ‘‘Generally Regarded As Safe.’’ Applica-
tions of PHA have been shown to improve barrier function in
both neonatal and aged rodent skin (Fluhr et al., 2004; Choi
et al., 2007a), and even to ‘‘super-normalize’’ barrier
function in normal mice (Hachem et al., 2009), and in
humans (Gunathilake, 2009). Current forms of therapy for
AD, regardless of type, could readily exploit these findings
simply by ensuring that the vehicle used for topical
applications is buffered to achieve a sustained reduction in
the pH of diseased SC. Alternatively, SC pH could also be
manipulated indirectly by stimulating activity or expression
of endogenous epidermal acidifying mechanisms, such as
the NHE1 antiporter and/or secretory phospholipase A2
(Elias, 2005). Both topical peroxisome proliferator activator
receptor-a and liver-X receptor activators have already been
deployed successfully to normalize SC acidity (and epidermal
structure and function) in neonatal murine skin (Fluhr et al.,
2005, 2008), and our recent results suggest their use in
attenuating AD in a murine model (Hatano et al., in
preparation). Nevertheless, the use of all of these approaches
for human AD remains to be assessed.
MATERIALS AND METHODS
Materials
Female hairless mice (h/h), aged 6–8 weeks old, were purchased
from Charles River Laboratories (Wilmington, MA) and fed on a
mouse diet (Ralston-Purina Co., St Louis, MO) and water ad libitum.
Ethanol was purchased from Fisher Scientific (Fairlane, NJ). Ox and
LBA were purchased from Sigma Chemical Co. (St Louis, MO).
Rabbit anti-mouse antibody against the prostaglandin D receptor,
Ox+nLBA
Nm+Veh
Ox+LBA
Ox+nLBA
Nm+Veh
Ox+LBA
Figure 7. Maintenance of normal SC pH normalizes both serine protease
(SP) and lipid-processing enzyme activities. (a and b) Skin samples were
collected 48 hours after the tenth challenge with Ox for the assessment of both
(a) SP and (b) b-glucocerebrosidase activities by in situ zymography (see
Materials and Methods). Green stain in (a) represents SP activity; red
counterstain in (a) represents nuclear staining with propidium iodide. Intense
red staining in (b) represents b-glucocerebrosidase activity. Bar¼ 20mm.
SG
SC
Ox+LBA
SG
Ox+LBASC
Ox+nLBASC
SG
TC
SG
Ox+Veha
b
d
c
Figure 8. Maintenance of an acidic pH normalizes lamellar body (LB) secretion. (a) Ox-AD mice were cotreated twice daily with ethanol vehicle (Veh) above.
Note the accumulation of LBs in apical cytosol of upper stratum granulosum (SG) (open arrows), consistent with partial blockade of secretion. (b) Using lipase
cytochemistry, retention (entombment) of some LB contents (open arrows) can be seen within nascent corneocytes (TC¼ transitional cells). Solid arrows show
normally secreted, extracellular contents. (c) Ox-AD mice cotreated with LBA display normal pattern of nearly complete secretion of LB contents at stratum
granulosum (SG)–stratum corneum (SC) interface (solid arrows). (d) Efficiency of secretion in LBA-cotreated mice is shown independently with lipase
ultrastructural cytochemistry (Note: all enzyme activity (short arrows) in SC is extracellular; cf. b). (a–d) Osmium tetroxide postfixation. Bar¼ 0.5 mm.
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CRTH2/DP2, was from Cayman Chemical (Ann Arbor, MI). Goat
anti-mouse antibodies against mBD3, IL-1a, and TNFa were
purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit
anti-human antibody against CD3 was purchased from Dako
(Glostrup, Denmark). Biotinylated goat anti-rabbit IgG antibody
and biotinylated horse, anti-goat antibody were purchased from
Vector Laboratories (Burlingame, CA). Biotinylated mAb against
PCNA was purchased from CalTag Laboratories (Burlingame, CA).
Primary rabbit anti-mouse mBD3 antibody was purchased from
Alpha Diagnostics (San Antonio, TX) and the primary rabbit anti-
CRAMP antibody was a gift from Dr Gallo (UCSD). FITC-conjugated
goat anti-rabbit secondary antibody was purchased from Alpha
Diagnostics.
Experimental protocols
All animal procedures were approved by the Animal Studies
Subcommittee of the San Francisco Veterans Administration Medical
Center and performed in accordance with their guidelines. Animals
were sensitized with a single topical application of 1% Ox (50ml) to
the flank. To assess the effects of acidification in acute allergic
contact dermatitis, Ox (0.1%) or vehicle was then applied 1 week
later to the ears, as described previously (Sheu et al., 2002; Fowler
et al., 2003). We generated mice with an AD-like dermatosis, using
the protocol described by Man et al. (2008). One week after Ox
sensitization, hairless mice were treated topically with 60 ml of 0.1%
Ox on both flanks once every other day for an additional 3 weeks
(totally, 10 challenges over 20–21 days (Man et al., 2008)). Atopic
mice were divided into three groups at the beginning of challenges,
depending on the kind of the additional treatment, that is,
applications of 60 ml of 10% LBA, 10% neutralized LBA (nLBA), or
the ethanol-containing vehicle (water/ethanol 7:3 vol/vol) twice
daily on both flanks. nLBA was produced by neutralization of LBA
with NaOH for a control. An additional control group comprised
animals that were treated with the ethanol vehicle alone (no hapten
treatments). LBA, nLBA, or vehicle were applied twice daily at an
interval of 6 hours at least 1 hour after previous hapten treatment. In
the acute allergic contact dermatitis mice, LBA, nLBA, and vehicle
were applied either 2 hours before Ox challenge or immediately
before Ox challenge.
Functional studies
Basal TEWL was measured with an electrolytic water analyzer
(Meeco, Warrington, PA), and SC hydration, assessed as electrical
capacitance, was measured with a Corneometer CM820 (Courage &
Khazaka, Cologne, Germany) (Choi et al., 2005), 48 hours after the
final Ox challenge. SC surface pH was measured concurrently with a
flat glass, surface electrode (Mettler-Toledo, Giessen, Germany),
attached to a pH meter (PH900; Courage & Khazaka) as described
previously (Hachem et al., 2005a, b). pH at different levels of SC and
within SC microdomains was assessed by dual-photon, fluorescence
life-time imaging (FLIM), using 2,7-bis-(2-carboxyEthyl)-5-(and-6-)
carboxyfluorescein (BCECF) as the fluorophore (Behne et al., 2002).
To evaluate the effect of pre- or co-acidification on the intensity of
inflammation elicited by single Ox challenge, alterations in ear
thickness were assessed histologically and with a dial thickness
gauge (Ozaki Seisakusho Co., Tokyo, Japan), 3, 6, 24, and 48 hours
after the Ox challenge.
Immunohistochemistry and immunofluorescence
Immunohistochemical staining for CRTH2, IL-1a, TNFa, and CD3
was performed as described previously (Demerjian et al., 2006; Man
A B
SC
SC
SC
Ox+LBAOx+nLBA
SC
Figure 9. Maintenance of an acidic pH normalizes lamellar bilayer
structure. (a) Ox-AD mice cotreated with either vehicle or nLBA show a
paucity of lamellar bilayers (vehicle not shown) and failure of lamellar bilayer
formation (also see Figure 10 below). (b) Ox-AD mice cotreated with LBA
show rapid formation of mature lamellar bilayers in SC extracellular spaces
(Figure 9b, arrows). (a and b) Ruthenium tetroxide postfixation. Bar¼ 0.1 mm.
A
SC
SC
SC
Ox+Veh
B
C
SC
SC Ox+LBA
SC
SC
Ox+nLBAa b
c
Figure 10. Maintenance of an acidic pH normalizes post-secretory lipid
processing. (a and b) Ox-AD mice cotreated with either nLBA or vehicle show
secreted lamellar material that is incompletely processed into lamellar
bilayers (arrows). (c) At a comparable level of stratum corneum (SC), Ox-AD
mice cotreated with LBA show abundant, fully processed and mature lamellar
bilayers (arrows). (a–c) Ruthenium tetroxide postfixation. Bar¼0.2 mm.
  
OX+GC
  
OX+Veh
  
OX+LBA
  
OX+nLBA
Figure 11. Maintenance of an acidic pH decreases epidermal IL-1a
production. Ox-AD mice cotreated with either nLBA or vehicle (not shown)
exhibit increased immunostaining for IL-1a (see Materials and Methods). The
expected increase is blocked by cotreatment with LBA, but the glucocorticoid
(clobetasol) has little effect. Paraffin-embedded sections: secondary antibody
detected by the ABC-peroxidase method. Bar¼20 mm.
1832 Journal of Investigative Dermatology (2009), Volume 129
Y Hatano et al.
Maintenance of an Acidic SC Prevents Murine AD
et al., 2008). Briefly, 5-mm paraffin-embedded sections were
incubated with the primary antibodies overnight at 4 1C. After
washing  3, sections were incubated with the secondary antibody
for 30minutes. Staining was detected with the ABC-peroxidase kit
(Vector Labs). The density of CRTH2-positive cells, eosinophils
assessed in hematoxylin-and-eosin-stained sections, mast cells
detected by toluidine blue stain, and the CD3-positive cells in the
area of 220mm 170 mm were counted in more than 15 fields in the
dermis of each sample.
CRAMP and mBD3 were detected in 5-mm frozen sections, using
rabbit polyclonal antibodies against the mouse proteins (CRAMP
antibody was a gift from Dr Gallo). After incubation with the
secondary anti-rabbit and anti-goat antibodies, sections were visua-
lized and photographed in a confocal microscope (Leica TCS-SP).
To assess changes in the epidermal proliferation, changes in the
overall morphology were visualized after hematoxylin-and-eosin
staining of 5-mm paraffin-embedded sections, and proliferating cells
were detected and quantitated by PCNA staining. Briefly, 5-mm
paraffin sections were incubated with biotinylated mAb against
PCNA (Ki67 antigen) overnight at 4 1C, and positive staining was
detected by the ABC-peroxidase method, as described above.
Sections were examined with a Zeiss light microscope (Jena,
Germany), and digital images were captured with AxioVision
software (Carl Zeiss Vision, Munich, Germany). Epidermal thickness
in hematoxylin-and-eosin sections was measured with AxioVision
software. Measurements were performed in more than 15 fields of
intervals of 100mm in each sample. The number of PCNA-positive
cells observed within 50 mm length of epidermis was counted at
more than 10 points for each sample.
For immunofluorescence detention of mBD3 and CRAMP, freshly
obtained biopsies were snap-frozen in liquid nitrogen. Five-micro-
meter frozen sections were soaked in acetone for 10minutes,
washed in phosphate-buffered saline, and blocked with 4% BSA and
0.05% cold fish gelatin in phosphate-buffered saline for 30minutes.
Slides were incubated overnight at 4 1C with either the CRAMP or
mBD3 primary antibodies, followed by incubation with the
secondary antibody for 40minutes at room temperature. Some
slides were counterstained with propidium iodide and examined in a
Leica TCS-SP confocal microscope.
Zymographic assessment of enzyme activity
Serine protease activity was assessed in freshly obtained skin
samples by in situ zymography, as described previously (Hachem
et al., 2003, 2005b). Five-micrometer frozen sections were
incubated with BODIPY-FI0-casein for 2 hours at 37 1C. b-glucocer-
ebrosidase was detected using 4-methylumbelliferyl-b-D-glucoside
as the substrate, as described previously (Takagi et al., 1999). After
3 washing with 1% Tween-20, sections were counter-stained with
propidium iodide and examined with the confocal microscope, as
described above.
Serum IgE and thymus and activation-regulated cytokine
measurements
Blood samples were collected from mice after 10 Ox- or vehicle-
challenges, and serum IgE levels were determined with a mouse IgE
ELISA quantitation kits from Bethyl Laboratories (Montgomery, TX),
following the instructions provided by the manufacturer. Serum
thymus and activation-regulated cytokine (TARC) levels were
measured by ELISA, using a quantitation kit (Quantikine) from
R&D Systems (Minneapolis, MN).
Electron microscopy
Skin biopsies from both vehicle and 10 Ox-treated mice were
fixed in Karnovsky’s fixative overnight, and postfixed with either
0.25% ruthenium tetroxide or 1% aqueous osmium tetroxide,
containing 1.5% potassium ferrocyanide, as described previously
(Hou et al., 1991). Ultrathin sections were examined using an
electron microscope (Zeiss 10A, Carl Zeiss, Thornwood, NY),
operated at 60 kV.
Ultrastructural lipase detection
Ultrastructural cytochemistry of various lipases serve as content
markers for epidermal LBs, allowing assessment of the efficacy of
organelle secretion (Menon et al., 1992), as modified from Nagata
(Nagata and Murata, 1972). Briefly, samples were incubated in 5%
Tween 85 (1ml) in 0.2M HEPES buffer (2.5ml), 2.5% sodium
taurocholate (2ml), and 10% calcium chloride (1ml) in 25ml
distilled water (pH 7.4). Microwave incubations were performed, as
described previously (Rassner et al., 1997). Microwave incubations
were performed twice for 30 seconds at 2,450MHz and the water
bath was changed between the pulses, to maintain temperatures
below 40 1C. The samples then were further incubated in the same
medium for an additional 30minutes at 37 1C. After incubations, all
samples were processed for electron microscopy (see above). As
controls, duplicate samples were preincubated in 0.1M cacodylate
buffer containing 0.2% Tween 85 with or without 200mm of the
lipase inhibitor, tetrahydrolipstatin (Hochuli et al., 1987), and
incubated as above.
Statistical analyses
Data are expressed as means±SEM. A two-tailed Student’s t-test was
used to determine significant differences between two groups. An
ANOVA analysis was performed when three or more groups were
compared.
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SUPPLEMENTARY MATERIAL
Figure S1. Pre-acidification does not prevent Ox-induced acute allergic
contact dermatitis.
Figure S2. Co-acidification prevents development of barrier abnormality, but
not inflammation in Ox-induced acute allergic dermatitis.
Figure S3. No change in serum thymus and activation-regulated cytokine
levels after co-acidification of Ox-AD mice.
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